Study of Datopotamab Deruxtecan Plus Carboplatin or Cisplatin Versus Gemcitabine Plus Carboplatin or Cisplatin in Participants With Locally Advanced or Metastatic Urothelial Carcinoma

Recruiting

Phase 2 — Testing in a larger group (up to a few hundred people) to further evaluate safety and begin to assess effectiveness.

Trial locations(79 sites)

United States

Research Site, Fullerton, California

Research Site, La Jolla, California

Research Site, San Francisco, California

Research Site, Aurora, Colorado

Research Site, Orange City, Florida